Bharat Srinivasa
Fondateur chez Amplitude Ventures
Profil
Bharat Srinivasa is the founder of Amplitude Ventures (2018) and Reverb Therapeutics (2023).
He is currently a Director at Radiant Biotherapeutics, Inc. (2020 - present).
He previously worked as CEO & Director at Ability Biologics, Inc., Director at Angiochem, Inc. (2018 - 2022), Director at Thrasos Therapeutics, Inc. (2017 - 2018), Independent Director at Surgical Safety Technologies, Inc. (2022 - 2023), and Senior Analyst at BDC Venture Capital (2015 - 2018).
Dr. Srinivasa received his graduate and doctorate degrees from McGill University in 2010 and 2014, respectively, and his undergraduate degree from the University of Toronto in 2008.
Postes actifs de Bharat Srinivasa
Sociétés | Poste | Début |
---|---|---|
Amplitude Ventures
Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada. | Fondateur | 01/07/2018 |
Reverb Therapeutics | Fondateur | 01/01/2023 |
Radiant Biotherapeutics, Inc.
Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021. | Directeur/Membre du Conseil | 01/07/2020 |
Anciens postes connus de Bharat Srinivasa
Sociétés | Poste | Fin |
---|---|---|
Surgical Safety Technologies, Inc.
Surgical Safety Technologies, Inc. Information Technology ServicesTechnology Services Surgical Safety Technologies, Inc. improves surgical performance and safety while reducing healthcare costs. The company is based in Toronto, Canada. The Canadian company was founded by Teodor Grantcharov. | Directeur/Membre du Conseil | 01/04/2023 |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | 01/05/2022 |
BDC Venture Capital
BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Private Equity Investor | 01/06/2018 |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | 01/03/2018 |
Ability Biologics
Ability Biologics BiotechnologyHealth Technology Ability Biologics, Inc. develops and manufactures immune modulating biotherapeutics and human therapeutic ready antibodies. The company is based in Montréal, Canada. It was founded by Giles Day and Jean-Philippe Bürckert, with Giles Day serving as the CEO since incorporation. | Directeur Général | - |
Formation de Bharat Srinivasa
McGill University | Doctorate Degree |
University of Toronto | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 8 |
---|---|
BDC Venture Capital
BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Finance |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Surgical Safety Technologies, Inc.
Surgical Safety Technologies, Inc. Information Technology ServicesTechnology Services Surgical Safety Technologies, Inc. improves surgical performance and safety while reducing healthcare costs. The company is based in Toronto, Canada. The Canadian company was founded by Teodor Grantcharov. | Technology Services |
Amplitude Ventures
Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada. | Finance |
Radiant Biotherapeutics, Inc.
Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021. | Health Technology |
Reverb Therapeutics | |
Ability Biologics
Ability Biologics BiotechnologyHealth Technology Ability Biologics, Inc. develops and manufactures immune modulating biotherapeutics and human therapeutic ready antibodies. The company is based in Montréal, Canada. It was founded by Giles Day and Jean-Philippe Bürckert, with Giles Day serving as the CEO since incorporation. | Health Technology |